Diagnosis and Biomarkers for Hematologic Malignancies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 21
Special Issue Editors
Interests: diagnosis in hematological neoplasms; lymphoma; myeloid neoplasms; immunohistochemistry; molecular biology; biomarkers; MYC; LMO2
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine and Surgery (DIMEC), University of Bologna, 40126 Bologna, Italy
Interests: acute myeloid leukemia; acute lymphoblastic leukemia; stem cell transplantation (autologous and allogeneic); novel therapies; stem cell manipulation; cryopreservation and characterization; cell therapy in onco-hematological disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent decades, a profound transformation has occurred in the diagnostic approach to hematological disorders, transitioning from a traditional morphological assessment to sophisticated molecular profiling, with an increasing emphasis on multidisciplinary diagnostic strategies. A meticulous diagnosis is essential for precise prognostic stratification and optimized therapeutic selection. Although a microscopic examination of tissues, blood and bone marrow remains the critical foundational assessment, contemporary diagnostic frameworks are progressively defining hematological entities through the sophisticated exploration of underlying molecular and genetic disease mechanisms.
This Special Issue, entitled “Diagnosis and Biomarkers for Hematologic Malignancies”, aims to highlight novel diagnostic and prognostic tools that could improve the management and treatment of hematological neoplasms.
Dr. Luis Colomo
Prof. Dr. Francesco Lanza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematologic malignancies
- diagnosis
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
